Novel strategies for immortalization of human hepatocytes

Artificial Organs

Volumn 25, Issue 7, 2001, Pages 529-538

  Cascio, Stephanie M ^a,b  

^a MultiCell Technologies Inc   (United States)

^b BROWN UNIVERSITY   (United States)

Author keywords

Human hepatocyte cell lines; Immortalization; Reversible immortalization; Telomerase

Indexed keywords

ARTIFICIAL ORGANS; CHROMOSOMES;

CELL LINES; HUMAN HEPATOCYTE CELL LINE; HUMAN HEPATOCYTES; IMMORTALIZATION; LIFESPANS; NOVEL STRATEGIES; REVERSIBLE IMMORTALIZATION; SOMATIC CELLS; TELOMERASE; TELOMERE LENGTH;

CELL CULTURE;

TELOMERASE;

CELL LINE; CELL SURVIVAL; CELL TRANSPLANTATION; DRUG EFFECT; GRAFT REJECTION; HUMAN; LIVER CELL; LIVER FAILURE; METHODOLOGY; PHYSIOLOGY; REVIEW; SENSITIVITY AND SPECIFICITY; TISSUE PRESERVATION; TRANSPLANTATION;

CELL LINE; CELL SURVIVAL; CELL TRANSPLANTATION; GRAFT REJECTION; HEPATOCYTES; HUMANS; LIVER FAILURE; SENSITIVITY AND SPECIFICITY; TELOMERASE; TISSUE PRESERVATION;

EID: 0035408523     PISSN: 0160564X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1594.2001.025007529.x     Document Type: Article

References (74)

1. Stange J, Mitzner SR, Risler T, Erley CM, Lauchart W, Goehl H, Klammt S, Peszynski P, Freytag J, Hickstein H, Lohr M, Liebe S, Schareck W, Hopt UT, Schmidt R. Molecular adsorbent recycling system (MARS): Clinical results of a new membrane-based blood purification system for bioartificial liver support. Artif Organs 1999;23:319-30.
2. Ash SR. Hemodiabsorption in treatment of acute hepatic failure and chronic cirrhosis with ascites. Artif Organs 1994;18: 355-62.
3. Naik S, Trenkler D, Santangini H, Pan J, Jauregui HO. Isolation and culture of porcine hepatocytes for artificial liver support. Cell Transplant 1996;5:107-15.
4. Sussman NL, Gislason GT, Conlin CA, Kelly JH. The Hepatix extracorporeal liver assist device: Initial clinical experience. Artif Organs 1994;18:390-6.
5. Chapman LE, Heneine W, Switzer W, Sandstrom P, Folks TM. Xenotranplantation: The potential for xenogeneic infections. Transplant Proc 1999;31:909-10.
6. Takeuchi Y, Weiss R. Xenotransplantation: Reappraising the risk of retroviral zoonosis. Curr Opin Immunol 2000;12:504-7.
7. Heneine W, Tibell A, Switzer WM, Sandstrom P, Vazquez Rosales G, Mathews A, Korsgren O, Chapman LE, Folks TM, Groth CG. No evidence of infection with porcine endogenous retrovirus in recipients of porcine islet-cell xenografts. Lancet 1998;352:695-9.
8. Paradis K, Langford G, Long Z, Heneine W, Sandstrom P, Switzer WM, Chapman LE, Lockey C, Onions D, The XEN 111 Study Group, Otto E. Search for cross-species transmission of porcine endogenous retrovirus in patients treated with living pig tissue. Science 1999;285:1236-41.
9. Patience C, Patton GS, Takeuchi Y, Weiss RA, McClure MO, Rydberg L, Breimer ME. No evidence of pig DNA or retroviral infection in patients with short-term extracorporeal connection to pig kidneys. Lancet 1998;352:699-701.
10. Pitkin Z, Mullon C. Evidence of absence of porcine endogenous retrovirus (PERV) infection in patients treated with a bioartificial liver support system. Artif Organs 1999;23: 829-33.
11. Fox IJ, Roy Chowdhury J, Kaufman SS, Goertzen TC, Roy Chowdhury N, Warkentin PI, Dorko K, Sauter BV, Strom SC. Treatment of the Crigler-Najar syndrome type I with hepatocyte transplantation. N Engl J Med 1998;338:1422-6.
12. Kobayashi N, Fujiwara T, Westerman KA, Inoue Y, Sakaguchi M, Noguchi H, Miyazaki M, Cai J, Tanaka N, Fox IJ, Leboulch P. Prevention of acute liver failure in rats with reversibly immortalized human hepatocytes. Science 2000;287: 1258-62.
13. Fang G, Cech TR. Telomere proteins. In: Blackburn EH, Greider CW, eds. Telomeres. Cold Spring Harbor Press, 1995: 69-105.
14. Blackburn EH. Structure and function of telomeres. Nature 1992;350:569-73.
15. Zakian VA. Telomeres: Beginning to understand the end. Science 1995;270:1601-7.
16. Martens UM, Chavez EA, Poon SSS, Schmoor C, Lansdorp PM. Accumulation of short telomeres in human fibroblasts prior to replicative senescence. Exp Cell Res 2000;256:291-9.
17. Harley CB. Telomeres and aging. In: Blackburn EH, Greider CW, eds. Telomeres. Cold Spring Harbor Press, 1995:247-63.
18. Allsopp RC, Vaziri H, Patterson C, Goldstein S, Younglai EV, Futcher AB, Greider CW, Harley CB. Telomere length predicts replicative capacity of human fibroblasts. PNAS 1992;89:10114-8.
19. Klapper W, Heidorn K, Kuhne K, Parwaresch R, Krupp G. Telomerase in "immortal" fish. FEBS Lett 1998;434:409-12.
20. Klapper W, Kuhne K, Singh KK, Heidorn K, Parwaesch R, Krupp G. Longevity of lobsters is linked to ubiquitous telomerase expression. FEBS Lett 1998;439:143-6.
21. Beattie TL, Zhou W, Robinson MO, Harrington L. Reconstitution of human telomerase activity in vitro. Curr Biol 1998; 8:177-80.
22. Chiu C-P, Harley CB. Replicative senescence and cell immortality: The role of telomeres and telomerase. Proc Soc Exp Biol Med 1997;214:99-106.
23. Bryan TM, Reddel RR. Telomere dynamics and telomerase activity in vitro immortalized human cells. Eur J Cancer 1997; 33:767-73.
24. Shay JW, Bacchetti S. A survey of telomerase activity in human cancer. Eur J Cancer 1997;33:787-91.
25. Hayflick L, Moorhead PS. The serial cultivation of human diploid cell strains. Exp Cell Res 1961;25:585-621.
26. Hayflick L. The limited in vitro lifespan of human diploid cell strains. Exp Cell Res 1965;37:614-36.
27. Campisi J. Cancer, aging and cellular senescence. In Vivo 2000;14:183-8.
28. Shay JW, Pereira-Smith OM, Wright WE. A role for both RB and p53 in the regulation of human cellular senescence. Exp Cell Res 1991;196:33-9.
29. Lustig AJ. Crisis intervention: The role of telomerase. PNAS 1999;96:3339-41.
30. Monalto MC, Phillips JS, Ray FA. Telomerase activation in human fibroblasts during escape from crisis. J Cell Physiol 1999;180:46-52.
31. Sherr CJ, DePinho RA. Cellular senescence: Mitotic clock or culture shock. Cell 2000;102:407-10.
32. Rohme D. Evidence for a relationship between longevity of mammalian species and life spans of normal fibroblasts in vitro and erythrocytes in vivo. PNAS 1981;78:5009-13.
33. Sigel MM, Beasley AR. Marine teleost fish tissues. In: Kruse PF, Patterson MK, eds. Tissue Culture, Methods and Applications. New York: Academic Press, 1973:123-28.
34. Freed JJ, Metzger-Freed L. Stable haploid cultured cell lines from frog embryos. PNAS 1970;65:337-44.
35. Pereira-Smith OM, Smith JR. Genetic analysis of indefinite division in human cells: Identification of four complementation groups. PNAS 1988;85:6042-6.
36. Banga SS, Kim S, Hubbard K, Dasgupta T, Jha KK, Patsalis P, Hauptschein R, Gamberi B, Dalla-Favera R, Kraemer P, Ozer HL. SEN6, a locus for SV40-mediated immortalization of human cells, maps to 6q26-27. Oncogene 1997;14:313-21.
37. Pereira-Smith OM, Ning Y, Weber JL, Killary AM, Ledbetter DH, Smith JR. Genetic analysis of indefinite division in human cells: Evidence for a cell-senescence related gene(s) on human chromosome 4. PNAS 1991;88:5635-9.
38. Hensler PJ, Annab LA, Barrett JC, Pereira-Smith OM. A gene involved in control of human cellular senescence on human chromosome 1q. Mol Cell Biol 1994;14:2291-7.
39. Ogata T, Oshimura M, Namba M, Fuji M, Oishi M, Ayusawa D. Genetic complementation of the immortal phenotype in group D cell lines by introduction of chromosome 7. Jpn J Cancer Res 1993;86:35.
40. Bertram MJ, Smith JR, Pereira-Smith OM, Berube NG, Hang-Swanson X, Ran Q, Leung JK, Bryce S, Spurgers K, Bick RJ, Baldini A, Ning Y, Clark LJ, Parkinson EK, Barrett JC. Identification of a gene that reverses the immortal phenotype of a subset of cells and is a member of a novel family of transcription factor-like genes. Mol Cell Biol 1999;19: 1479-85.
41. Shelton DN, Chang E, Whittier PS, Choi D, Funk WD. Microarray analysis of replicative senescence. Curr Biol 1999;9: 939-45.
42. Lundberg AS, Hahn WC, Gupta P, Weinberg RA. Genes involved in senescence and immortalization. Curr Opin Cell Biol 2000;12:705-9.
43. Kamijo T, Bodner S, van de Kamp E, Randle DH, Sherr CJ. Tumor spectrum in ARF deficient mice. Cancer Res 1999;59: 2217-22.
44. Runge D, Runge DM, Jager D, Lubecki KA, Stolz DB, Karathanasis S, Kietzmann T, Strom SC, Jungermann K, Fleig WE, Michalpoulos GK. Serum-free, long-term cultures of human hepatocytes: Maintenance of cell morphology, transcription factors and liver specific functions. Biochem Biophys Res Commun 2000;269:46-53.
45. Fausto N. Liver regeneration. J Hepatol 2000;32:19-31.
46. Overturf K, Al-Dhalimy M, Ou C-N, Finegold M, Grompe M. Serial transplantation reveals the stem-cell like regenerative potential of adult mouse hepatocytes. Am J Pathol 1997;151: 1273-80.
47. Yamaguchi Y, Nozawa K, Savoysky E, Hayakawa N, Nimura Y, Yoshida S. Change in telomerase activity of rat organs during growth and aging. Exp Cell Res 1998;242:120-7.
48. Tsujiuchi T, Tsutsumi M, Takahama M, Sakitani H, Iki K, Sasaki Y, Denda A, Konishi Y. Induction of telomerase activity during regeneration after partial hepatectomy in the rat. Cancer Lett 1998;122:115-20.
49. Golubovskaya VM, Presnell SC, Hooth MJ, Smith GJ, Kaufmann WK. Expression of telomerase in normal and malignant rat epithelia. Oncogene 1997;15:1233-40.
50. Ogami M, Ikura Y, Nishiguchi S, Kuroki T, Ueda M, Sakurai M. Quantitative analysis and in situ localization of human telomerase RNA in chronic liver disease and hepatocellular carcinoma. Lab Invest 1999;79:15-26.
51. Gruppuso PA, Bienieki TC, Faris RA. The relationship between differentiation and proliferation in late gestation fetal rat hepatocytes. Pediatr Res 1999;46:14-9.
52. Haber B, Naji L, Cressman D, Taub R. Coexpression of liver-specific and growth-induced genes in perinatal and regenerating liver: Attainment and maintenance of the differentiated state during rapid proliferation. Hepatology 1995;22:906-4.
53. Bryan TM, Reddel RR. SV40-induced immortalization of human cells. Crit Rev Oncogenesis 1994;5:331-57.
54. Radna RL, Caton Y, Jha KK, Kaplan P, Li G, Traganos F, Ozer HL. Growth of immortal simian virus 40 tsA-transformed human fibroblasts is temperature dependent. Mol Cell Biol 1989;9:3093-6.
55. Berghella L, De Angelis L, Coletta M, Berarducci B, Sonnino C, Salvatori G, Anthonissen C, Cooper R, Butler-Browne GS, Mouly V, Ferrari G, Mavilio F, Cossu G. Reversible immortalization of human myogenic cells by site-specific excision of a retrovirally transferred oncogene. Hum Gene Ther 1999;10: 1607-17.
56. Kobayashi N, Noguchi H, Watanabe T, Matsumura T, Totsugawa T, Fujiwara T, Westerman K, Leboulch P, Fox IJ, Tanaka N. Establishment of a tightly regulated human cell line for the development of hepatocyte transplantation. Hum Cell 2000;13:7-13.
57. Westerman KA, Laboulch P. Reversible immortalization of mammalian cells mediated by retroviral transfer and site specific recombination. PNAS 1996;93:8971-6.
58. Sauer B, Henderson N. Site-specific DNA recombination in mammalian cells by the Cre recombinase of bacteriophage P1. PNAS 1988;85:5166-70.
59. Cai J, Ito M, Westerman KA, Kobayashi N, Leboulch P, Fox IJ. Construction of a non-tumorigenic rat hepatocyte cell line for transplantation: Reversal of hepatocyte immortalization by site specific excision of the SV40 T antigen. J Hepatol 2000;33:701-8.
60. Salmon P, Oberholzer J, Occhiodoro T, Morel P, Lou J, Trono D. Reversible immortalization of human primary cells by lenti-vector mediated transfer of specific genes. Mol Ther 2000;2:404-14.
61. Kiyono T, Foster SA, Koop JI, McDougall JK, Galloway DA, Klingelhutz AJ. Both RB/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells. Nature 1998;396:84-8.
62. Dickson MA, Hahn WC, Ino Y, Ronfard V, Wu JY, Weinberg RA, Louis DN, Li FP, Rheinwald JG. Human keratinocytes that express hTERT and also bypass a p16INK4a mechanism that limits life span become immortal yet retain normal growth and differentiation characteristics. Mol Cell Biol 2000;20:1436-47.
63. Zhu J, Wang H, Bishop JM, Blackburn EH. Telomerase extends the lifespan of virus transformed human cells without net telomere lengthening. PNAS 1999;96:3723-8.
64. Counter CM, Hahn WC, Wei W, Dickinson Caddle S, Beijersbergen RL, Lansdorp PM, Sedivy JM, Weinberg RA. Dissociation among in vitro telomerase activity, telomere maintenance, and cellular immortalization. PNAS 1998;95: 14723-8.
65. Beckman KB, Ames BN. The free radical theory of aging matures. Physiol Rev 1998;78:547-81.
66. Bodner AG, Ouellette M, Frolkis M, Holt SE, Chiu CP, Morin GB, Harley CB, Shay JW, Lichtsteiner S, Wright WE. Extension of lifespan by introduction of telomerase into normal human cells. Science 1998;279:349-52.
67. Vaziri H, Benchimol S. Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative lifespan. Curr Biol 1998;8:279-82.
68. Morales CP, Holt SE, Ouellette M, Kaur KJ, Yan Y, Wilson KS, White MA, Wright WE, Shay JW. Absence of cancer associated changes in human fibroblasts immortalized with telomerase. Nat Genet 1999;21:115-8.
69. Jiang XR, Jimenez G, Chang E, Frolkis M, Kusler B, Sage M, Beeche M, Bodnar AG, Wahl GM, Tlsty TD, Chiu C-P. Telomerase expression in human somatic cells does not induce changes associated with a transformed phenotype. Nat Genet 1999;21:111-4.
70. Serrano M, Hannon GJ, Beach D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclinD/CDK4. Nature 1993;366:704-7.
71. Farwell DG, Shera KA, Koop JI, Bonnet GA, Matthews CP, Reuther GW, Coltrera MD, McDougall JK, Klingelhutz AJ. Genetic and epigenetic changes in human epithelial cells immortalized by telomerase. Am J Pathol 2000;156:1537-47.
72. MacKenzie KL, Franco S, May C, Sadelain M, Moore MAS. Mass cultured human fibroblasts overexpressing hTERT encounter a growth crisis following an extended period of proliferation. Exp Cell Res 2000;259:336-50.
73. Wang J, Hannon GJ, Beach DH. Risky immortalization by telomerase. Nature 2000;405:755-6.
74. Wang J, Xie LY, Allan S, Beach D, Hannon GJ. Myc activates telomerase. Genes Dev 1998;12:1769-74.